CompletedNCT01727414
Methylphenidate Response in Children With Inattentive or Combined ADHD
About this title
Read the official source — NCT01727414Medication studyAges 7–11United States
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 7 years to 11 years. Other eligibility criteria applied.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 171
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 7 Years to 11 Years
- Official registry ID
- NCT01727414
- Official title
Show the full official title
Medication Response in Children With Predominately Inattentive Type ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including OROS-Methylphenidate and placebo for inattentive type pts and OROS-Methylphenidate and placebo for combined type pts.
Who was this study for?
This study was for people with ADHD. Listed age limits: 7 years to 11 years. Other eligibility criteria applied.
